10-Q/A: Globalink Files Restated Q1, Faces Delisting & Liquidity Woes

Globalink Investment Inc. filed an amended quarterly report, restating financials due to redemption calculation errors, while grappling with Nasdaq delisting and significant liquidity concerns.

Summary

• Globalink Investment Inc. filed an Amendment No. 1 to its Quarterly Report on Form 10-Q for the three months ended March 31, 2025, to amend and restate its financial statements due to errors in calculating and reporting common stock subject to possible redemption and the redemption price per share.
• The restatement was prompted by an overpayment to redeeming stockholders in December 2024, where the per share redemption price was incorrectly calculated at $11.76793003 instead of approximately $11.52149928.
• A material weakness in internal control over financial reporting was identified, specifically related to the calculation and review of common stock subject to possible redemption and the redemption price per share.
• The company reported a net loss of $738,555 for the three months ended March 31, 2025, a significant increase from a net loss of $375,307 for the same period in 2024.
• Cash available to meet working capital needs was $3,468 as of March 31, 2025, with a working capital deficit of approximately $6.8 million.
• Globalink was delisted from Nasdaq, with trading suspended on December 17, 2024, and the delisting becoming effective on May 19, 2025; its securities are now quoted on the OTC Pink.
• The company is pursuing a business combination with Alps Global Holding Pubco and Alps Life Sciences Inc. (Alps Holdco), with amendments to the Merger Agreement removing earn-out provisions and net tangible asset requirements.
• PIPE investments totaling $40,200,000 were terminated, with new subscriptions for $3,279,911, of which $1,124,361 has been received by PubCo's escrow agent.
• An excise tax liability of $1,477,147 was recorded as of March 31, 2025, including $163,662 in interest and penalties for unpaid excise tax.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to significant financial losses, severe liquidity issues, a material weakness in internal controls, the termination of substantial PIPE investments, and the delisting from Nasdaq. While the company is still pursuing a business combination, these factors raise substantial doubt about its ability to continue as a going concern and successfully complete the transaction.

Positives

• General and administrative expenses decreased to $270,256 for the three months ended March 31, 2025, from $603,471 in the prior year period.
• Net cash used in operating activities improved to $160,039 for the three months ended March 31, 2025, compared to $885,807 in the prior year period.
• The Merger Agreement with Alps Holdco was amended to remove the earn-out provision and the $5,000,001 net tangible asset requirement, potentially simplifying the transaction.
• The Merger Agreement was further amended to remove the continued Nasdaq listing as a closing condition, allowing the business combination to proceed despite the delisting.

Negatives

• The company reported a significantly increased net loss of $738,555 for the three months ended March 31, 2025, compared to $375,307 for the same period in 2024.
• Cash on hand outside the Trust Account plummeted to $3,468 as of March 31, 2025, from $253,507 at December 31, 2024.
• A working capital deficit of approximately $6.8 million as of March 31, 2025, indicates severe liquidity issues.
• Interest income on cash held in the Trust Account decreased substantially to $32,099 for the three months ended March 31, 2025, from $342,667 in the prior year period.
• Tax penalties and interest surged to $163,662 for the three months ended March 31, 2025, from $2,356 in the prior year, primarily due to unpaid excise tax.
• Interest expense significantly increased to $285,197 for the three months ended March 31, 2025, from $33,395 in the prior year, reflecting increased borrowing.
• The company was delisted from Nasdaq effective May 19, 2025, and its securities now trade on the OTC Pink, which typically implies lower liquidity and investor interest.
• Original PIPE investments totaling $40 million were terminated, indicating a significant reduction in anticipated capital for the business combination.
• Management identified a material weakness in internal control over financial reporting related to the calculation and reporting of common stock subject to possible redemption and the review of the redemption price per share.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to its liquidity condition and the mandatory liquidation date of June 9, 2025, if a business combination is not consummated or an extension is not requested.
• Failure to complete a business combination by June 9, 2025, will result in mandatory liquidation and dissolution of the company.
• The company needs to raise additional capital through loans or investments from its sponsor, stockholders, officers, directors, or third parties, and there is no assurance such financing will be available on acceptable terms, if at all.
• The 1% U.S. federal excise tax on stock repurchases, including redemptions, could reduce cash available for a business combination and the company's ability to complete one, with unpaid amounts subject to 10% interest and 5% monthly penalties.
• The delisting from Nasdaq may negatively impact the company's ability to attract investors and complete the business combination, despite management's intent to proceed.
• The issuance of additional shares of common stock in connection with a business combination may significantly dilute existing equity interests and could cause a change in control.
• Incurring significant debt could lead to default, acceleration of obligations, inability to obtain additional financing, and reduced funds for operations and dividends.
• The company is subject to risks related to increases in inflation, rising interest rates, financial market instability, potential government shutdowns, and geopolitical events, which could negatively affect its financial position and ability to complete a business combination.

Future Outlook

The company intends to complete a business combination before the mandatory liquidation date of June 9, 2025, and expects to continue proceeding with the transactions contemplated by the Merger Agreement despite its Nasdaq delisting. Management plans to enhance processes for applying accounting requirements and improve review of common stock subject to possible redemption to address identified material weaknesses in internal controls.

Management Comments

• Management determined that the principal per share price reported in the original Form 10-Q for Q1 2025 did not consider additional extension payments and interest earned for non-redeeming stockholders, necessitating the restatement.
• Management has concluded that a material weakness exists in the company's internal control over financial reporting related to calculating and reporting common stock subject to possible redemption and the review of the redemption price per share.
• Management plans to further review and consult with legal and other professionals to ensure an understanding of obligations related to common stock subject to possible redemption and will review common stock redemption prior to all filings to ensure accuracy.
• Management has determined that the mandatory liquidation, should a business combination not occur and an extension is not requested by the sponsor, and the current liquidity condition raise substantial doubt about the company's ability to continue as a going concern.
• The company expects to continue proceeding with the transactions contemplated by the Merger Agreement despite the delisting of its securities from Nasdaq.

Industry Context

Globalink Investment Inc. operates as a Special Purpose Acquisition Company (SPAC), a sector that has faced increased scrutiny and challenges, including higher redemption rates and difficulties in completing business combinations within mandated timelines. The company's delisting from Nasdaq for failing to complete a business combination within 36 months is a common risk for SPACs, often leading to a loss of investor confidence and reduced liquidity as securities move to over-the-counter markets. The significant redemptions and the need for multiple extensions highlight the broader market's skepticism towards SPACs that struggle to identify and close suitable target acquisitions, especially in a tightening capital market environment.

Comparison to Industry Standards

• The company's failure to complete a business combination within 36 months, leading to Nasdaq delisting, is a negative deviation from typical SPAC timelines and listing requirements.
• The high redemption rates experienced by Globalink (e.g., 2,285,056 shares redeemed in December 2024, 2,180,738 shares in November 2023, 6,756,695 shares in March 2023) are significantly higher than the average redemption rates seen in successful SPACs, indicating a lack of investor confidence in the proposed business combination or the SPAC's prospects.
• The substantial working capital deficit of $6.8 million and minimal cash on hand ($3,468) are far below the liquidity levels typically maintained by operating companies or even healthy SPACs nearing a business combination, signaling severe financial distress.
• The termination of $40 million in PIPE investments, followed by new, much smaller subscriptions of $3.48 million, suggests a significant downgrade in investor interest and capital commitment compared to initial expectations, which is a negative indicator for the perceived value of the target business (Alps Holdco) and the combined entity.
• The ongoing reliance on related-party promissory notes and advances for working capital and extension payments, totaling over $4.5 million, is common for distressed SPACs but deviates from the ideal scenario where a SPAC would have sufficient independent capital or strong third-party investor backing.

Management Changes

Corporate Governance

Legal Proceedings

• None mentioned in the filing.

Related Party Transactions

• Public Gold Marketing Sdn. Bhd., a related party due to a familial relationship with the sponsor's controlling member, provided multiple promissory notes totaling $4,507,595 (principal and interest) as of March 31, 2025, bearing 6% interest per annum and repayable upon business combination.
• On March 6, 2025, $2 million of the outstanding promissory notes from Public Gold Marketing Sdn. Bhd. were agreed to be due in cash within 60 days of closing, with the remaining balance convertible into PubCo ordinary shares at $10.00 per share.
• An affiliate of the company's sponsor advanced $390,000, which was amended on March 24, 2025, to be convertible into ordinary shares of PubCo at $10.00 per share at closing.
• The company's chief executive officer deposited $60,000 into the trust account on March 6, 2025, reflected as 'Due to affiliate'.
• The company previously paid its sponsor $10,000 per month for administrative services until the agreement was terminated on September 30, 2023, with $217,000 accrued under this arrangement as of March 31, 2025.

Stakeholder Impact

• **Shareholders (Public Stockholders)**: Face significant dilution risk from potential issuance of additional shares for the business combination and conversion of related-party debt. The Nasdaq delisting reduces liquidity and market visibility, potentially impacting share value. The restatement and internal control weakness raise concerns about financial reporting reliability. High redemption rates indicate a loss of capital for those who redeemed, while remaining shareholders bear increased risk.
• **Sponsor/Initial Stockholders**: Have provided significant loans and advances to the company, indicating a strong commitment to completing the business combination, but also exposing them to substantial financial risk if the transaction fails. Their Founder Shares are subject to transfer restrictions tied to the business combination's completion.
• **Alps Global Holding Pubco / Alps Life Sciences Inc. (Target)**: The amendments to the Merger Agreement, particularly the removal of the Nasdaq listing condition, are favorable for the target as they remove a significant hurdle to closing. However, the reduced PIPE investment and Globalink's liquidity issues could impact the capital available to the combined entity post-merger.
• **Underwriters (Chardan Capital Markets LLC)**: Their deferred underwriting fees of $4,025,000 are contingent on the business combination's completion. The May 22, 2025, agreement to receive Alps Holdco shares in lieu of cash, contingent on a July 31, 2025, closing, indicates a high-risk arrangement to secure their payment.
• **Creditors (Public Gold Marketing Sdn. Bhd., Dr. Tham Seng Kong)**: Are exposed to the risk of the business combination not closing, as repayment of promissory notes is contingent on this event. The conversion of a portion of related-party debt into equity also shifts their position from creditor to equity holder, with associated risks.

Next Steps

• Complete the business combination with Alps Global Holding Pubco and Alps Life Sciences Inc. before the mandatory liquidation date of June 9, 2025.
• Raise additional capital through loans or investments from its sponsor, stockholders, officers, directors, or third parties to address working capital needs.
• Management will further review and consult with legal and other professionals to ensure an understanding of obligations related to common stock subject to possible redemption.
• Management will further review common stock redemption prior to any and all filings to ensure its accuracy and proper representation of company obligations.
• PubCo is obligated to file a registration statement to register for the resale of all PIPE Shares within 60 days of the Closing of the Business Combination.
• The company must ensure the business combination closes no later than July 31, 2025, for Chardan Capital Markets LLC to receive shares as full satisfaction of fees.

Key Dates

Recommendation

The company faces severe financial distress, evidenced by a significant net loss, minimal cash on hand, and a substantial working capital deficit. The identified material weakness in internal controls raises serious concerns about financial reporting reliability. Furthermore, the delisting from Nasdaq to the OTC Pink market drastically reduces liquidity and investor confidence. The termination of a large portion of the PIPE investment and the ongoing reliance on related-party financing underscore the difficulty in securing independent capital. With a mandatory liquidation date of June 9, 2025, and management expressing substantial doubt about the company's ability to continue as a going concern, the risk of total capital loss is extremely high. Even if the business combination with Alps Holdco closes, the combined entity will inherit significant financial challenges and a history of operational and governance issues. A seasoned investor would view these factors as overwhelmingly negative, warranting an immediate exit from the position.

Keywords

SPAC, Globalink Investment Inc., Alps Global Holding Pubco, Alps Life Sciences Inc., 10-Q/A, Restatement, Financial Reporting, Internal Controls, Liquidity, Going Concern, Nasdaq Delisting, Business Combination, Merger Agreement, PIPE Investment, Redemption, Excise Tax, Related Party Transactions